Cargando…
Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study
BACKGROUND: Although infrequent, some rheumatoid arthritis (RA) patients achieve disease-modifying antirheumatic drug (DMARD)-free sustained remission. The absence of RA-specific autoantibodies, such as anticitrullinated protein antibodies (ACPA), is known to be associated with this outcome but furt...
Autores principales: | Burgers, L. E., Boeters, D. M., Reijnierse, M., van der Helm-van Mil, A. H. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894211/ https://www.ncbi.nlm.nih.gov/pubmed/29636084 http://dx.doi.org/10.1186/s13075-018-1553-8 |
Ejemplares similares
-
MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF
por: Boeters, Debbie M., et al.
Publicado: (2016) -
ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation
por: Boeters, Debbie M., et al.
Publicado: (2019) -
DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability
por: Verstappen, M, et al.
Publicado: (2020) -
What is the additional value of MRI of the foot to the hand in undifferentiated arthritis to predict rheumatoid arthritis development?
por: Dakkak, Y. J., et al.
Publicado: (2019) -
Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
por: Verstappen, M., et al.
Publicado: (2020)